Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-22-000047
Filing Date
2022-08-08
Accepted
2022-08-08 07:50:49
Documents
57
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20220630.htm   iXBRL 10-Q 1115480
2 EX-31.1 krys-20220630ex311.htm EX-31.1 10786
3 EX-31.2 krys-20220630ex312.htm EX-31.2 10749
4 EX-32.1 krys-20220630ex321.htm EX-32.1 11258
10 GRAPHIC krys-20220630_g1.jpg GRAPHIC 229310
  Complete submission text file 0001711279-22-000047.txt   6031224

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20220630.xsd EX-101.SCH 36887
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20220630_cal.xml EX-101.CAL 55466
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20220630_def.xml EX-101.DEF 141634
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20220630_lab.xml EX-101.LAB 473377
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20220630_pre.xml EX-101.PRE 294985
51 EXTRACTED XBRL INSTANCE DOCUMENT krys-20220630_htm.xml XML 986610
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 221142594
SIC: 2836 Biological Products, (No Diagnostic Substances)